Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ulrike Helbig"'
Autor:
Anton Berns, Ulrik Ringborg, Julio E. Celis, Manuel Heitor, Neil K. Aaronson, Nancy Abou‐Zeid, Hans‐Olov Adami, Kathi Apostolidis, Michael Baumann, Alberto Bardelli, René Bernards, Yvonne Brandberg, Carlos Caldas, Fabien Calvo, Caroline Dive, Angelika Eggert, Alexander Eggermont, Carolina Espina, Frederik Falkenburg, Jérôme Foucaud, Douglas Hanahan, Ulrike Helbig, Bengt Jönsson, Mette Kalager, Sakari Karjalainen, Miklós Kásler, Pamela Kearns, Klas Kärre, Denis Lacombe, Francesco deLorenzo, Françoise Meunier, Gerd Nettekoven, Simon Oberst, Péter Nagy, Thierry Philip, Richard Price, Joachim Schüz, Eric Solary, Peter Strang, Josep Tabernero, Emile Voest
Publikováno v:
Molecular Oncology, Vol 14, Iss 8, Pp 1589-1615 (2020)
A comprehensive translational cancer research approach focused on personalized and precision medicine, and covering the entire cancer research–care–prevention continuum has the potential to achieve in 2030 a 10‐year cancer‐specific survival f
Externí odkaz:
https://doaj.org/article/938c652480cf4543b4c52b6778cd7da0
Publikováno v:
Forum. 37:38-41
Publikováno v:
Der Onkologe. 28:62-68
Zusammenfassung Hintergrund Die Zahl der Krebserkrankungen wird sich in den nächsten Jahren deutlich erhöhen. Liegt die Zahl der Neuerkrankungen in Deutschland aktuell bei rund 500.000 pro Jahr, prognostizieren Experten für 2030 einen Anstieg um 2
Publikováno v:
Forum. 34:527-536
Psychosoziale Krebsberatungsstellen (KBS) sind fester Bestandteil einer gestuften psychoonkologischen Versorgung. Indem sie Krebskranke und ihre Angehorigen unterstutzen, nehmen sie im ambulanten Sektor eine besondere Stellung ein. Angesichts der ang
Autor:
Olaf Ortmann, Ulrike Helbig
Publikováno v:
Forum. 34:10-13
Autor:
Kathi Apostolidis, Alexander M.M. Eggermont, Simon Oberst, Hans-Olov Adami, Fabien Calvo, Carlos Caldas, Ulrik Ringborg, Thierry Philip, Nancy Abou-Zeid, Josep Tabernero, Gerd Nettekoven, Francesco De Lorenzo, Neil K. Aaronson, Richard Price, Michael Baumann, Sakari Karjalainen, Emile E. Voest, Miklós Kásler, Frederik Falkenburg, Angelika Eggert, Bengt Jönsson, Douglas Hanahan, Mette Kalager, Péter Nagy, Caroline Dive, Manuel Heitor, Anton Berns, René Bernards, Ulrike Helbig, Eric Solary, Julio E. Celis, Carolina Espina, Klas Kärre, Pamela Kearns, Peter Strang, Françoise Meunier, Joachim Schüz, Alberto Bardelli, Jérôme Foucaud, Denis Lacombe, Yvonne Brandberg
Publikováno v:
Molecular Oncology, Vol 14, Iss 8, Pp 1589-1615 (2020)
Molecular Oncology
Scientia
Molecular Oncology
Scientia
A comprehensive cancer approach covering the entire research–care–prevention continuum can achieve a 10‐year cancer‐specific survival for 75% of patients diagnosed in EU member states with well‐developed health care by 2030. To ensure acces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da36c5f61c979213e70bcb1ed8a224c5
http://hdl.handle.net/2318/1857842
http://hdl.handle.net/2318/1857842
Autor:
Olaf, Ortmann, Ulrike, Helbig, Julie, Torode, Stefan, Schreck, Sakari, Karjalainen, Manola, Bettio, Ulrik, Ringborg, Monika, Klinkhammer-Schalke, Freddy, Bray, Simone, Wesselmann
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 144:1097-1102
National Cancer Control Plans (NCCPs) often describe structural requirements for high quality cancer care. During the fourth European Roundtable Meeting (ERTM) participants shared learnings from their own national setting to formulate best practice i
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 142:807-811
It is widely accepted that National Cancer Control Plans (NCCPs) are essential to improve cancer care. They often describe the structural requirements such as cancer centers, clinical cancer registries and quality control. During the 2nd European rou
Autor:
Sylvie Lorenzen, Ulrike Helbig, Florian Weißinger, G.M. Haag, Michael Pohl, Josef Rüschoff, Elisabeth Schnoy, Jorge Riera Knorrenschild, Gertraud Stocker, Klaus Becker, Andreas Eisenmenger, Florian Bassermann, Peter C. Thuss-Patience, Irini Karapanagiotou-Schenkel, Florian Lordick
Publikováno v:
European Journal of Cancer. 51:569-576
Introduction Human epidermal growth factor receptor 2 (HER2) amplification is present in a subgroup of gastroo-esophageal cancers (GCs). HER2 inhibition with trastuzumab has shown to improve outcomes in advanced disease. Lapatinib ditosylate (LAP), a
Publikováno v:
Info Onkologie. 14:50-52